Cargando…
Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC)
BACKGROUND: Laboratory assays are needed for early stage non-small lung cancer (NSCLC) that can link molecular and clinical heterogeneity to predict relapse after surgical resection. We technically validated two miRNA assays for prediction of relapse in NSCLC. Total RNA from seventy-five formalin-fi...
Autores principales: | Dahlgaard, Jesper, Mazin, Wiktor, Jensen, Thomas, Pøhl, Mette, Bshara, Wiam, Hansen, Anker, Kanisto, Eric, Hamilton-Dutoit, Stephen Jacques, Hansen, Olfred, Hager, Henrik, Ditzel, Henrik J, Yendamuri, Sai, Knudsen, Steen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221722/ https://www.ncbi.nlm.nih.gov/pubmed/22011393 http://dx.doi.org/10.1186/1756-0500-4-424 |
Ejemplares similares
-
Expression of MicroRNAs in the NCI-60 Cancer Cell-Lines
por: Patnaik, Santosh K., et al.
Publicado: (2012) -
Development and Blind Clinical Validation of a MicroRNA Based Predictor of Response to Treatment with R-CHO(E)P in DLBCL
por: Knudsen, Steen, et al.
Publicado: (2015) -
Clinical Impact of a Novel MicroRNA Chemo-Sensitivity Predictor in Gastrooesophageal Cancer
por: Winther, Mette, et al.
Publicado: (2016) -
Planned FDG PET-CT Scan in Follow-Up Detects Disease Progression in Patients With Locally Advanced NSCLC Receiving Curative Chemoradiotherapy Earlier Than Standard CT
por: Pan, Yi, et al.
Publicado: (2015) -
Development and Validation of a Gene Expression Score That Predicts Response to Fulvestrant in Breast Cancer Patients
por: Knudsen, Steen, et al.
Publicado: (2014)